These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28780618)

  • 61. Interleukin-17 mRNA expression and serum levels in Behçet's disease.
    Jadideslam G; Kahroba H; Ansarin K; Sakhinia E; Abhar A; Alipour S; Farhadi J; Seydi Shirvani S; Nouri-Vaskeh M; Mousavi S; Khabbazi A
    Cytokine; 2020 Mar; 127():154994. PubMed ID: 31951967
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model.
    Shim J; Lee ES; Park S; Bang D; Sohn S
    Cytotherapy; 2011 Aug; 13(7):835-47. PubMed ID: 21506890
    [TBL] [Abstract][Full Text] [Related]  

  • 63. IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestations.
    Talaat RM; Sibaii H; Bassyouni IH; El-Wakkad A
    Eur Cytokine Netw; 2019 Mar; 30(1):15-22. PubMed ID: 31122907
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
    Hamzaoui K; Bouali E; Ghorbel I; Khanfir M; Houman H; Hamzaoui A
    Med Sci Monit; 2011 Apr; 17(4):CR227-34. PubMed ID: 21455110
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of infliximab on gene expression profiling in Behcet's disease.
    Keino H; Watanabe T; Taki W; Okada AA
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7681-6. PubMed ID: 21862654
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: An involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen.
    Yanagihori H; Oyama N; Nakamura K; Mizuki N; Oguma K; Kaneko F
    J Invest Dermatol; 2006 Jul; 126(7):1534-40. PubMed ID: 16514412
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists.
    Vollmer S; Strickson S; Zhang T; Gray N; Lee KL; Rao VR; Cohen P
    Biochem J; 2017 Jun; 474(12):2027-2038. PubMed ID: 28512203
    [TBL] [Abstract][Full Text] [Related]  

  • 68. IL-1R-associated kinase-1 mediates protein kinase Cδ-induced IL-1β production in monocytes.
    Tiwari RL; Singh V; Singh A; Barthwal MK
    J Immunol; 2011 Sep; 187(5):2632-45. PubMed ID: 21804018
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease.
    Düzgün N; Ayaşlioğlu E; Tutkak H; Aydintuğ OT
    Rheumatol Int; 2005 Jan; 25(1):1-5. PubMed ID: 14600787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Visfatin levels in Behcet's disease.
    Sezen H; Okumus S; Pehlivan Y; Dilli I; Tarakcioğlu M; Onat AM
    Inflammation; 2012 Apr; 35(2):405-8. PubMed ID: 21494798
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet's disease.
    Hirohata S; Oka H; Mizushima Y
    Cell Immunol; 1992 Apr; 140(2):410-9. PubMed ID: 1544169
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Rs12569232 SNP Association with Vogt-Koyanagi-Harada Disease and Behcet's Disease is Probably Mediated by Regulation of Linc00467 Expression.
    Wang Q; Yi S; Du Z; Huang X; Xu J; Cao Q; Su G; Kijlstra A; Yang P
    Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1464-1470. PubMed ID: 32400232
    [No Abstract]   [Full Text] [Related]  

  • 73. Imbalance of Th17 to Th1 cells in Behçet's disease.
    Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of IRAK4 and IRF3 in the control of intracellular infection with Chlamydia pneumoniae.
    Trumstedt C; Eriksson E; Lundberg AM; Yang TB; Yan ZQ; Wigzell H; Rottenberg ME
    J Leukoc Biol; 2007 Jun; 81(6):1591-8. PubMed ID: 17360955
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Possibility of inducing anterior chamber-associated immune deviation by TGF-beta2 treatment of monocytes isolated from Behcet's patients.
    Takeuchi M; Keino H; Suzuki J; Usui Y; Hattori T; Takeuchi A; Oh-I K; Okunuki Y; Kezuka T; Usui M
    Exp Eye Res; 2006 Oct; 83(4):981-8. PubMed ID: 16822510
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HSP 60 expression in mucocutaneous lesions of Behçet's disease.
    Ergun T; Ince U; Ekşioğlu-Demiralp E; Direskeneli H; Gürbüz O; Gürses L; Aker F; Akoğlu T
    J Am Acad Dermatol; 2001 Dec; 45(6):904-9. PubMed ID: 11712037
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Induced interleukin-19 contributes to cell-mediated immunosuppression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Yeh CH; Cheng BC; Hsu CC; Chen HW; Wang JJ; Chang MS; Hsing CH
    Ann Thorac Surg; 2011 Oct; 92(4):1252-9. PubMed ID: 21855850
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity.
    Evereklioglu C; Inalöz HS; Kirtak N; Doganay S; Bülbül M; Ozerol E; Er H; Ozbek E
    Br J Dermatol; 2002 Aug; 147(2):331-6. PubMed ID: 12174107
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Decreased expression of the aryl hydrocarbon receptor in ocular Behcet's disease.
    Wang C; Ye Z; Kijlstra A; Zhou Y; Yang P
    Mediators Inflamm; 2014; 2014():195094. PubMed ID: 25045206
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characteristics of T cell lines established from skin lesions of Behçet's disease.
    Mochizuki M; Morita E; Yamamoto S; Yamana S
    J Dermatol Sci; 1997 May; 15(1):9-13. PubMed ID: 9186807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.